Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Price:
611.48
USD
1.63%
Market Closed
Market Cap:
$64.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
US |
|
P
|
Palatin Technologies Inc
LSE:0KF3
|
US |
|
Apollo Commercial Real Estate Finance Inc
NYSE:ARI
|
US |
|
E
|
Extreme Networks Inc
SWB:EXM
|
US |
|
Enova International Inc
NYSE:ENVA
|
US |
|
CureVac NV
NASDAQ:CVAC
|
DE |
|
L
|
LyondellBasell Industries NV
XBER:DLY
|
UK |
|
F
|
First Horizon Corp
DUS:FT2
|
US |
|
LKQ Corp
NASDAQ:LKQ
|
US |
|
Arix Bioscience PLC
LSE:ARIX
|
UK |
Multiples-Based Value
The Multiples-Based Value for Regeneron Pharmaceuticals Inc (REGN) under the Base Case is hidden
USD.
Compared with the current market price of 611.48 USD, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
REGN Multiples-Based Value
LOCKED
